Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography
82%
Neoplasm
52%
Positron Emission Tomography
49%
Image Quality
47%
Fluorodeoxyglucose F 18
37%
Zirconium 89
21%
Radioactive Tracer
18%
Molecular Imaging
16%
Polyethylene Terephthalate
14%
Immunoglobulin
13%
Low Drug Dose
13%
Cardiovascular Disease
13%
Nuclear Medicine
12%
Fluorine-18
9%
Personalized Medicine
9%
Standardized Uptake Value
8%
Immunotherapy
8%
Whole Body PET
8%
Radioisotope
7%
Cardiovascular System
7%
Oxygen 15
6%
Dosimetry
6%
Clinical Oncology
6%
Immune Checkpoint Inhibitor
6%
Non-Hodgkin Lymphoma
6%
Computer Assisted Tomography
6%
Radiomics
6%
Polymyalgia Rheumatica
6%
Trastuzumab
6%
Metastatic Melanoma
6%
Clinical Uncertainty
6%
Giant-Cell Arteritis
6%
Lymphocyte Activation
6%
Organ Segmentation
6%
Internal Carotid Artery
6%
Orthopedic Trauma Surgery
6%
Cytotoxic T-Cell
6%
Melanoma
6%
Diagnosis
6%
Photomultiplier
6%
Nonunion
5%
Ascending Aorta
5%
Radiation Exposure
5%
Nuclear Medicine Physician
5%
Keyphrases
Long Axial Field of View PET
41%
Positron Emission Tomography-computed Tomography (PET-CT)
37%
Input Function
23%
Patlak
23%
Whole-body
22%
18F-fluorodeoxyglucose (18F-FDG)
19%
Population-averaged
18%
Biograph Vision Quadra
16%
Long Axial Field of View
15%
Scan Duration
14%
Axial Field
14%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
13%
FDG-PET Scan
13%
PET Imaging
11%
PET Systems
11%
PET Scan
11%
SUVmax
10%
Healthy Tissue
10%
Image-derived Input Function
9%
PET Image
9%
Image Quality
8%
Tumor
8%
Positron-emitting Radionuclide
7%
Long-lived
7%
Lymph Node
7%
After Injection
7%
High Sensitivity
6%
Semi-quantitative Assessment
6%
Polymyalgia Rheumatica
6%
Automatic Workflow
6%
ImmunoPET
6%
Low-dose Imaging
6%
Activity Optimization
6%
Image Quality Optimization
6%
Ultra-low Dose
6%
Clinical Uncertainty
6%
Clinical Oncology
6%
Technology Performance
6%
Giant Cell Arteritis
6%
Computed Tomography Scanner
6%
Non-Hodgkin Lymphoma
6%
Immuno-positron Emission Tomography
6%
During Pregnancy
6%
Clinical Application
6%
89Zr-trastuzumab
6%
Image Quality Control
6%
PET Dosimetry
6%
Convolutional Neural Network
6%
Clinical Competence
6%
Tumor Demarcation
6%
